| Exercise Program of Breast Cancer Patients Undergoing Chemotherapy With or Without Radiation (NCT01157767) | Memorial Sloan Kettering Cancer Center | 2010-05-11 |
| Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI) (NCT01104584) | Bayer | 2010-05-01 |
| Iron Supplement in the Prevention of Anemia in Female Breast Cancer Patients (NCT01168505) | Instituto do Cancer do Estado de São Paulo | 2010-05-01 |
| Moderating the Negative Impact of Abnormal Screening Mammograms (NCT01153126) | University of Wisconsin, Madison | 2010-05-01 |
| Anti Cancer Stem Cell Activity of Pre-operative Bevacizumab and Chemotherapy in Breast Cancer (NCT01190345) | Institut Paoli-Calmettes | 2010-05-01 |
| A Pilot Study of Docosahexaenoic Acid (DHA) in Obese Menopausal Women (NCT01127867) | Rockefeller University | 2010-05-01 |
| Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life (NCT01134172) | Memorial Sloan Kettering Cancer Center | 2010-05-01 |
| Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Non-Metastatic, Post Menopausal Breast Cancer Patients (NCT01051609) | Jonsson Comprehensive Cancer Center | 2010-05-01 |
| Stanford Accelerated Recovery Trial (START) (NCT01067144) | Stanford University | 2010-05-01 |
| STI.VI. Study: How to Improve Lifestyles in Screening Contexts (NCT03118882) | Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte | 2010-05-01 |
| Regimens Comparison for Breast Cancers of Positive Lymph Nodes (NCT01134523) | Chinese Academy of Medical Sciences | 2010-05-01 |
| Study of an Intervention to Improve Problem List Accuracy and Use (NCT01105923) | Brigham and Women's Hospital | 2010-05-01 |
| Real World Efficiency of Trastuzumab in Early Breast Cancer (NCT01894711) | Maastricht University Medical Center | 2010-05-01 |
| Reducing Breast Cancer Recurrence With Weight Loss (NCT01112839) | University of California, San Diego | 2010-05-01 |
| Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting (NCT01387841) | Bharath Charitable Cancer Hospital and Institute | 2010-05-01 |
| Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer (NCT01195298) | South Eastern European Research Oncology Group | 2010-05-01 |
| Study of the Safety and Leukostimulatory Activity of the Preparation "Panagen" in Patients With Breast Cancer (NCT02115984) | Panagen, Limited Liability Company | 2010-05-01 |
| Determination of Predictive Genetic Markers of Toxicity After Hypofractionated Radiotherapy in Breast Cancer Patients Post-Conservative Surgery (NCT01316328) | Regina Elena Cancer Institute | 2010-05-01 |
| (Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer (NCT02627703) | British Columbia Cancer Agency | 2010-05-01 |
| Compound Herbal Formula (TPE-1) for Leukopenia and Cancer-related Fatigue in Breast Cancer Patients With Radiotherapy (NCT01142479) | Taipei City Hospital | 2010-05-01 |
| The Accuracy of Sentinel Node Biopsy of Breast Cancer With Sonographic Abnormal Axillary Lymph Nodes (NCT02005926) | Tao OUYANG | 2010-05-01 |
| Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer (NCT01086605) | Alliance for Clinical Trials in Oncology | 2010-05-01 |
| PET-MR for Prediction and Monitoring of Response to Neoadjuvant Chemotherapy in Breast Cancer (NCT01190566) | Seoul National University Hospital | 2010-05-01 |
| Screening Mammography and Latinas: A Multilevel Intervention (NCT02010008) | Fred Hutchinson Cancer Center | 2010-05-01 |
| Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases (NCT01290536) | Nicholas Fidelman, MD | 2010-05-01 |
| Efficacy of Capecitabine Metronomic Chemotherapy to Triple-negative Breast Cancer (NCT01112826) | Sun Yat-sen University | 2010-04-23 |
| An Observational Study of the Mean Duration of Trastuzumab (Herceptin) Treatment in Participants With Early or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer (NCT01187381) | Hoffmann-La Roche | 2010-04-14 |
| 18F-FLT-PET in Breast Cancer (MK-0000-139) (NCT01015131) | Merck Sharp & Dohme LLC | 2010-04-08 |
| Online Stress Management and Coping Skills Training for Women With Breast Cancer (NCT01335152) | Talaria, Inc | 2010-04-01 |
| Effect of Guided Imagery and Progressive Muscle Relaxation as a Means to Improve the Psychological Well-being and the Quality of Life for Patients With Breast and Prostate Cancer (NCT01275872) | Cyprus University of Technology | 2010-04-01 |
| Progressive Resistance Training Versus Relaxation for Breast Cancer Patients During Chemotherapy: Biological Mechanisms and Effects on Fatigue and Quality of Life (NCT01106820) | German Cancer Research Center | 2010-04-01 |
| Trial Comparing Perioperative Care for Breast Cancer Patients at a Patient Hotel vs a General Surgical Ward (NCT02403973) | Danderyd Hospital | 2010-04-01 |
| Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer (NCT01303419) | GE Healthcare | 2010-04-01 |
| Study of 0.1% Uracil Topical Cream (UTC) for the Prevention of Hand-Foot Syndrome (NCT01100463) | Nanometics (d.b.a. PHD Biosciences) | 2010-04-01 |
| Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer (NCT01111825) | Puma Biotechnology, Inc. | 2010-04-01 |
| S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer (NCT00856492) | SWOG Cancer Research Network | 2010-04-01 |
| Preoperative Localisation of the Sentinel Lymph Node in Breast Cancer (NCT01154972) | NHS Tayside | 2010-04-01 |
| Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer (NCT01104571) | Institute of Cancer Research, United Kingdom | 2010-04-01 |
| Image Evaluation of Philips Philips MammoDiagnost DR Full Field Digital Mammography System (FFDM) (NCT00999596) | Philips Healthcare | 2010-04-01 |
| RCT to Examine the Effects of Scanning (NCT01804621) | University of Pennsylvania | 2010-04-01 |
| A Trial Testing Professional and Peer-led Support Online Support Groups for Young Canadian Breast Cancer Survivors (NCT01089699) | British Columbia Cancer Agency | 2010-04-01 |
| Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer Patients (NCT01099436) | Borstkanker Onderzoek Groep | 2010-04-01 |
| Omega-3 Fatty Acids and Chemotherapy-induced Neuropathy and Inflammation in Breast Cancer (NCT01049295) | Tehran University of Medical Sciences | 2010-04-01 |
| A Nutritional Intervention and Physical Activity Program Reduce Body Weight in Women Newly Diagnosed With Breast Cancer. (NCT04980118) | Instituto de Investigación Hospital Universitario La Paz | 2010-04-01 |
| International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients (NCT01111201) | Memorial Sloan Kettering Cancer Center | 2010-04-01 |
| Quantitative MRI Assessment of Breast Cancer Therapy Response (NCT05704062) | Corewell Health East | 2010-03-18 |
| Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction (NCT01208974) | University of Miami | 2010-03-16 |
| A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers (NCT01086696) | National Cancer Institute (NCI) | 2010-03-09 |
| Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer (NCT01022138) | Barbara Ann Karmanos Cancer Institute | 2010-03-08 |
| Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ (NCT01132560) | ECOG-ACRIN Cancer Research Group | 2010-03-05 |
| Female Cancer Patients' Preference For Sexual Health Interventions (NCT01084642) | Memorial Sloan Kettering Cancer Center | 2010-03-04 |
| Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence (NCT01081509) | AstraZeneca | 2010-03-01 |
| Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer (NCT01009983) | Wake Forest University Health Sciences | 2010-03-01 |
| Study of Tamoxifen Dose Escalation in Breast Cancer Patients With CYP2D6 Polymorphisms (NCT01075802) | Western Sydney Local Health District | 2010-03-01 |
| Fluorescent Dyes for Lymph Node Mapping (NCT01095913) | M.D. Anderson Cancer Center | 2010-03-01 |
| FNA Tumor Sampling for CD137 Modulation: A Pilot Study (NCT01114256) | Stanford University | 2010-03-01 |
| The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer (NCT01080170) | University of Pittsburgh | 2010-03-01 |
| Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor (NCT01459653) | Sandoz | 2010-03-01 |
| Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab (NCT01009918) | University of South Florida | 2010-03-01 |
| Digital Mammography for the Detection and Preoperative Staging of Breast Cancer (NCT01086514) | Memorial Sloan Kettering Cancer Center | 2010-03-01 |
| Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome (NCT00946283) | Rutgers, The State University of New Jersey | 2010-03-01 |
| Effectiveness of a Cancer Center Based Physical Activity Intervention (NCT01173861) | East Carolina University | 2010-03-01 |
| GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers (NCT01118975) | University of Maryland, Baltimore | 2010-03-01 |
| Use of Harmonic in Breast Surgery (NCT01587248) | Aga Khan University | 2010-03-01 |
| I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer (NCT01042379) | QuantumLeap Healthcare Collaborative | 2010-03-01 |
| Effects of Internet Support for Cancer Patients (NCT00971009) | Oslo University Hospital | 2010-03-01 |
| Exercise Intervention in Breast Cancer Patients With Treatment-Induced Arthralgia (NCT01236417) | Roswell Park Cancer Institute | 2010-03-01 |
| Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial (NCT02839473) | Institut Curie | 2010-03-01 |
| Role of 3D Tomography in Breast Cancer (NCT01090687) | University of Rochester | 2010-03-01 |
| VEGF Early Imaging for Breast Cancer (NCT00991978) | University Medical Center Groningen | 2010-03-01 |
| Faith Moves Mountains: A Community Based Participatory Research (CBPR) Appalachian Wellness & Cancer Prevention Program (NCT01373320) | Nancy Schoenberg | 2010-03-01 |
| The Effect of Soy Protein on Post- Breast Cancer Surgery Pain (NCT01047774) | Dr. Yoram Shir | 2010-03-01 |
| A Study of Bevacizumab With Taxane Therapy in Participants With Triple Negative Breast Cancer (NCT01094184) | Hoffmann-La Roche | 2010-03-01 |
| Patient Perception of Mammogram Guidelines (NCT01267877) | University of Massachusetts, Worcester | 2010-03-01 |
| Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer (NCT01118624) | Acrotech Biopharma Inc. | 2010-03-01 |
| AX Versus AC as Adjuvant Treatment for Node-Negative Breast Cancer (NCT01415336) | Peking Union Medical College Hospital | 2010-03-01 |
| Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor (NCT01096381) | Vanderbilt-Ingram Cancer Center | 2010-03-01 |
| Assessing Response to Neoadjuvant Chemotherapy With HD PET/CT, Serum Glycomic Markers and Tissue Muc-1 Isoforms (NCT01110174) | University of California, Davis | 2010-03-01 |
| Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer (NCT01073865) | AstraZeneca | 2010-02-26 |
| Adipose Tissue Transfer for Moderate Breast Cancer Conservative Treatment Sequella (NCT01035268) | Institut Claudius Regaud | 2010-02-08 |
| Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum (NCT01042548) | University of Pittsburgh | 2010-02-03 |
| Measuring Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors (NCT01074320) | HealthPartners Institute | 2010-02-01 |
| Study To Investigate the Feasibility and Safety of A Dedicated High Resolution Nuclear Breast Imaging Camera (NCT01062100) | Ontario Clinical Oncology Group (OCOG) | 2010-02-01 |
| Xpress Digital Mammography System Images for Computer Aided Detection Development (NCT01061138) | Konica Minolta Medical Imaging, USA | 2010-02-01 |
| PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations (NCT01074970) | Hoosier Cancer Research Network | 2010-02-01 |
| 89Zr-trastuzumab PET for Imaging the Effect of HSP90 Inhibition (NCT01081600) | University Medical Center Groningen | 2010-02-01 |
| Imaging of ER Density to Guide and Improve Tailored Therapy for Acquired Anti-hormonal Resistant Breast Cancer (NCT01088477) | University Medical Center Groningen | 2010-02-01 |
| Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimen (NCT01042925) | Sanofi | 2010-02-01 |
| Evaluation of the Diagnostic Performance of MRI±Biopsy to Optimize Resection of Ductal Carcinoma In Situ (DCIS) Breast Cancer (NCT01112254) | Gustave Roussy, Cancer Campus, Grand Paris | 2010-02-01 |
| Patient Registry: Partial Breast Irradiation (NCT01127971) | Wake Forest University Health Sciences | 2010-02-01 |
| An Observational Follow-up Study of 1st-Line Treatment With Herceptin (Trastuzumab) in Patients With Metastatic Breast Cancer (Post-HERMINE) (NCT01332981) | Hoffmann-La Roche | 2010-02-01 |
| Imaging HSP90 Inhibitor AUY922 on VEGF-89ZR-bevacizumab Positron Emission Tomography (PET) (NCT01081613) | University Medical Center Groningen | 2010-02-01 |
| Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and Toxicity (NCT00886535) | Milton S. Hershey Medical Center | 2010-02-01 |
| DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer (NCT00972023) | Barbara Ann Karmanos Cancer Institute | 2010-02-01 |
| Musicotherapy in the Reduction of Fatigue in Women With Breast or Gynecological Cancer Under Radiotherapy (NCT01570218) | Universidade Federal de Goias | 2010-02-01 |
| Malmö Breast Tomosynthesis Screening Trial (NCT01091545) | Region Skane | 2010-02-01 |
| Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI (NCT01067976) | Bayer | 2010-02-01 |
| A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA) (NCT01026142) | Hoffmann-La Roche | 2010-01-26 |
| Psychometric Validation (Quality-of-life Scale) in Young Women With a Non Metastatic Breast Cancer and Her Partner (NCT02858063) | Centre Oscar Lambret | 2010-01-11 |
| A Randomized Controlled Mindfulness Based Stress Reduction Intervention in Women With Breast Cancer (NCT01591915) | Skaraborg Hospital | 2010-01-01 |